Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural insights into epitope-paratope interactions of a monoclonal antibody targeting CEACAM5-expressing tumors. | Nat Commun | 2024 | 39477960 | PubTator, text mining | PubMed |
| Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Orthotopic Cell Line Mouse Models. | J Clin Med | 2024 | 39458160 | PubTator, text mining | PubMed |
The Prospect of Improving Pancreatic Cancer Diagnostic Capabilities by Implementing Blood Biomarkers: A Study of Evaluating Properties of a Single IL-8 and in Conjunction with CA19-9, CEA, and CEACAM6. | Biomedicines | 2024 | 39457656 | PubTator, text mining | PubMed |
| Monoclonal antibody targeting CEACAM1 enhanced the response to anti-PD1 immunotherapy in non-small cell lung cancer. | Int Immunopharmacol | 2024 | 39426236 | PubTator, text mining | PubMed |
| Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series. | Cancers (Basel) | 2024 | 39410042 | PubTator, text mining | PubMed |
| A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome. | Int J Mol Sci | 2024 | 39408795 | PubTator, text mining | PubMed |
| The clinical value of combined detection of seven lung cancer-related autoantibodies in assisting the diagnosis of non-small-cell lung cancer. | Biomark Med | 2024 | 39360656 | PubTator, text mining | PubMed |
| Copper metabolism-related signature for prognosis prediction and MMP13 served as malignant factor for breast cancer. | Heliyon | 2024 | 39315182 | PubTator, text mining | PubMed |
| 2022-2023 Drug Updates: Investigational Therapeutics in the Pipeline. | J Adv Pract Oncol | 2024 | 39297063 | PubTator, text mining | PubMed |
| Erythematous plaque in the axilla. | JAAD Case Rep | 2024 | 39286827 | PubTator, text mining | PubMed |
| AI-enhanced diagnostic model for pulmonary nodule classification. | Front Oncol | 2024 | 39281372 | PubTator, text mining | PubMed |
| Enhancing Cell Aggregation and Migration via Double-Click Cross-Linking with Azide-Modified Hyaluronic Acid. | Bioconjug Chem | 2024 | 39213494 | PubTator, text mining | PubMed |
| Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies. | Proc Natl Acad Sci U S A | 2024 | 38968122 | PubTator, text mining | PubMed |
| Hypoxia exosome derived CEACAM5 promotes tumor-associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. | FASEB J | 2024 | 38923643 | PubTator, text mining | PubMed |
| Wilms' Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5. | Am J Clin Oncol | 2024 | 38898559 | PubTator, text mining | PubMed |
| Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody. | Ann Surg Oncol | 2024 | 38888861 | PubTator, text mining | PubMed |
| CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course. | BJUI Compass | 2024 | 38873357 | PubTator, text mining | PubMed |
| [High expression of ATP5A1 in gastric carcinoma is correlated with a poor prognosis and enhanced glucose metabolism in tumor cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 38862456 | PubTator, text mining | PubMed |
| Simultaneous screening of overexpressed genes in breast cancer for oncogenic drivers and tumor dependencies. | Sci Rep | 2024 | 38851782 | PubTator, text mining | PubMed |
| The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks. | Cancer Cytopathol | 2024 | 38829774 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=10